Myeloid cells, such as immunosuppressive macrophages, play a significant role in shaping the immunosuppressive tumor microenvironment and are critical for tumor development. Consequently, blocking myeloid cells may offer a complementary strategy to checkpoint inhibitors and provide new treatment solutions for non-responsive or relapsing patients as well as expand the patient population responsive to immunotherapies.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.